Ophthalmology

Graves disease: correcting upper eyelid retraction
pp. 1713-1714(2)
Author: Frueh B.R.

Phacoemulsification after RD surgery
pp. 1714-1714(1)
Authors: Thomas R.; Braganza A.

PPA: automated lamellar keratoplasty
pp. 1714-1715(2)
Author: Binder P.S.

Acetazolamide treatment of CME in patients with uveitis
pp. 1715-1716(2)
Author: Flach A.

Acetazolamide treatment of CME in patients with uveitis
pp. 1717-1717(1)
Author: Rho D.

Intraocular lens implantation: has it become the standard of care for children?
pp. 1719-1720(2)
Author: Wilson M.E.

The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey
pp. 1721-1726(6)
Authors: Rahmani B.; Tielsch J.M.; Katz J.; Gottsch J.; Quigley H.; Javitt J.; Sommer A.

Change in visual acuity associated with cataract surgery. The Beaver Dam Eye Study
pp. 1727-1731(5)
Authors: Klein B.E.; Klein R.; Moss S.E.

Use of eye care services among the 1991 Medicare population
pp. 1732-1743(12)
Authors: Ellwein L.B.; Friedlin V.; McBean A.M.; Lee P.P.

Eye care for elderly Americans with diabetes mellitus. Failure to meet current guidelines
pp. 1744-1750(7)
Authors: Wang F.; Javitt J.C.

Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population
pp. 1751-1760(10)
Authors: Ariyasu R.G.; Lee P.P.; Linton K.P.; LaBree L.D.; Azen S.P.; Siu A.L.

The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report
pp. 1761-1766(6)
Authors: Peele K.A.; Kennerdell J.S.; Maroon J.C.; Kalnicki S.; Kazim M.; Gardner T.; Malton M.; Goodglick T.; Rosen C.

Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis
pp. 1768-1773(6)
Authors: Dunker S.; Wiegand W.

The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions
pp. 1774-1783(10)
Authors: Potter P.D.; Shields C.L.; Shields J.A.; Flanders A.E.

Abscessed hydroxyapatite orbital implants. A report of two cases
pp. 1784-1787(4)
Authors: Jordan D.R.; Brownstein S.; Jolly S.S.

Signet ring cell carcinoma of the eccrine sweat glands in the eyelid
pp. 1788-1793(6)
Authors: Wollensak G.; Witschel H.; Bohm N.

Echographic evaluation and findings in metastatic melanoma to extraocular muscles
pp. 1794-1797(4)
Authors: DiBernardo C.; Pacheco E.M.; Hughes J.R.; Iliff W.J.; Byrne S.F.

Open-globe injury. Update on types of injuries and visual results
pp. 1798-1803(6)
Authors: Pieramici D.J.; MacCumber M.W.; Humayun M.U.; Marsh M.J.; de Juan E.

Office repair of retinal detachment using a Lincoff Temporary balloon buckle
pp. 1804-1810(7)
Authors: Green S.N.; Yarian D.L.; Masciulli L.; Leff S.R.

Macular hole surgery. Comparison of longstanding versus recent macular holes
pp. 1811-1814(4)
Authors: Willis A.W.; Garcia-Cosio J.F.

Diabetic retinopathy during pregnancy
pp. 1815-1819(5)
Authors: Axer-Siegel R.; Hod M.; Fink-Cohen S.; Kramer M.; Weinberger D.; Schindel B.; Yassur Y.

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
pp. 1820-1828(9)
Authors: Tolentino M.J.; Miller J.W.; Gragoudas E.S.; Jakobiec F.A.; Flynn E.; Chatzistefanou K.; Ferrara N.; Adamis A.P.

Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization
pp. 1829-1836(8)
Authors: Tezel T.H.; Del Priore L.V.; Flowers B.E.; Grosof D.H.; Benenson I.L.; Zamora R.L.; Kaplan H.J.

Pre-injection fluorescence in indocyanine green angiography
pp. 1837-1845(9)
Authors: Piccolino F.C.; Borgia L.; Zinicola E.; Iester M.; Torrielli S.

Prognosticators for visual outcome in sarcoid uveitis
pp. 1846-1853(8)
Authors: Dana M.R.; Merayo-Lloves J.; Schaumberg D.A.; Foster C.S.

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group
pp. 1854-1862(9)
Authors: Hyndiuk R.A.; Eiferman R.A.; Caldwell D.R.; Rosenwasser G.O.; Santos C.I.; Katz H.R.; Badrinath S.S.; Reddy M.K.; Adenis J.P.; Klauss V.

Endophthalmitis associated with microbial keratitis
pp. 1864-1870(7)
Authors: Scott I.U.; Flynn H.W.; Feuer W.; Pflugfelder S.C.; Alfonso E.C.; Forster R.K.; Miller D.

Posterior capsulorhexis with optic capture in pediatric cataract and intraocular lens surgery
pp. 1871-1875(5)
Author: Gimbel H.V.

Changes in bacterial strains before and after cataract surgery
pp. 1876-1879(4)
Authors: Hara T.; Hoshi N.; Hara T.

The efficacy of topical metronidazole in the treatment of ocular rosacea
pp. 1880-1883(4)
Authors: Barnhorst D.A.; Foster J.A.; Chern K.C.; Meisler D.M.

Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice
pp. 1884-1888(5)
Authors: Francis B.A.; Chang E.L.; Haik B.G.

Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography
pp. 1889-1898(10)
Authors: Schuman J.S.; Pedut-Kloizman T.; Hertzmark E.; Hee M.R.; Wilkins J.R.; Coker J.G.; Puliafito C.A.; Fujimoto J.G.; Swanson E.A.

Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma
pp. 1899-1906(8)
Authors: Park K.H.; Tomita G.; Liou S.Y.; Kitazawa Y.

Autosomal-dominant iridogoniodysgenesis and Axenfeld-Rieger syndrome are genetically distinct
pp. 1907-1915(9)
Authors: Walter M.A.; Mirzayans F.; Mears A.J.; Hickey K.; Pearce W.G.

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups
pp. 1916-1924(9)
Authors: Camras C.B.; Alm A.; Watson P.; Stjernschantz J.

Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure
pp. 1925-1933(9)
Authors: Shin D.H.; Hughes B.A.; Song M.S.; Kim C.; Yang K.J.; Shah M.I.; Juzych M.S.; Obertynski T.

A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures
pp. 1934-1942(9)
Authors: Cohen J.S.; Greff L.J.; Novack G.D.; Wind B.E.

Noninvasive closure of a persistent cyclodialysis cleft
pp. 1943-1945(3)
Authors: Brooks A.M.; Troski M.; Gillies W.E.

Slit-lamp needle revision of failed filtering blebs using mitomycin C
pp. 1946-1955(10)
Authors: Mardelli P.G.; Lederer C.M.; Murray P.L.; Pastor S.A.; Hassanein K.M.

Gaussian optics for photorefractive keratectomy. Increased predictability for larger diopter corrections
pp. 1956-1961(6)
Authors: Colliac J.P.; Perez J.P.

Characteristics influencing outcomes of excimer laser photorefractive keratectomy. Summit Photorefractive Keratectomy Phase III Study Group
pp. 1962-1969(8)
Authors: Hersh P.S.; Schein O.D.; Steinert R.

Direct objective quantification of corneal haze after excimer laser photorefractive keratectomy for high myopia
pp. 1970-1978(9)
Authors: Maldonado M.J.; Arnau V.; Navea A.; Martinez-Costa R.; Mico F.M.; Cisneros A.L.; Menezo J.L.

Photorefractive keratectomy retreatments for regression. One-year follow-up
pp. 1979-1984(6)
Authors: Pop M.; Aras M.